Rapport Therapeutics (RAPP) Income Statement: Revenue & Earnings

Rapport Therapeutics Income Statement Analysis

Revenue, earnings, and profit margins in millions USD

Scale:

Scroll to see more

Rapport Therapeutics, Inc. income statement - Annual data in millions USD
Breakdown	FY 2024	FY 2023	FY 2022
Period Ending	Dec 2024	Dec 2023	Dec 2022
Revenue & Gross Profit
Revenue	0.00	0.00	0.00
Cost of Revenue	0.84	0.00	0.00
Gross Profit	-0.84	0.00	0.00
Operating Expenses
Research & Development	60.94	28.00	4.49
Selling, General & Administrative	22.12	8.18	1.37
Operating Expenses	82.22	36.18	5.85
Operating Income	-83.06	-36.18	-5.85
Other Income/Expense
Interest Income	12.14	2.53	0.00
Interest Expense	0.00	0.00	-0.31
Other Income/Expense	4.75	-1.12	0.00
Income
Income Before Tax	-78.31	-34.78	-11.62
Income Tax Expense	0.00	0.01	0.00
Net Income	-78.31	-34.79	-11.62
Net Income - Continuous Operations	-78.31	-34.79	0.00
Net Income - Discontinued Operations	0.00	0.00	0.00
EBITDA	-77.47	-36.07	-5.84
EBIT	-78.31	-36.18	-5.85
Depreciation & Amortization	0.84	0.11	0.02
Earnings Per Share
Basic EPS	-	-23.00	-15.00
Diluted EPS	-	-23.00	-15.00
Basic Shares Outstanding	207.38	1.51	0.78
Diluted Shares Outstanding	207.38	1.51	0.78